HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshiyuki Chiba Selected Research

VGA1155

8/2010The novel VEGF receptor antagonist, VGA1155, reduces edema, decreases infarct and improves neurological function after stroke in rats.
7/2008Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshiyuki Chiba Research Topics

Disease

2Ischemia
08/2010 - 07/2008
2Brain Edema (Cerebral Edema)
08/2010 - 07/2008
2Brain Ischemia (Cerebral Ischemia)
08/2010 - 07/2008
2Edema (Dropsy)
08/2010 - 07/2008
2Infarction (Infarctions)
08/2010 - 07/2008
1Infections
03/2019
1Rupture
02/2019
1Aneurysm (Aneurysms)
02/2019
1Carotid-Cavernous Sinus Fistula
02/2019
1Prolactinoma (Prolactinomas)
02/2019
1Tinnitus
02/2019
1Syphilis
05/2018
1Granuloma
05/2018
1Cognitive Dysfunction
01/2017
1Brain Injuries (Brain Injury)
08/2010
1Stroke (Strokes)
08/2010
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2008
1Urticaria (Hives)
03/2007
1Angioedema
03/2007
1Neoplasms (Cancer)
12/2005
1Extramammary Paget Disease (Paget Disease, Extramammary)
12/2005

Drug/Important Bio-Agent (IBA)

2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2010 - 07/2008
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2010 - 07/2008
2AcidsIBA
08/2010 - 07/2008
2VGA1155IBA
08/2010 - 07/2008
2Evans Blue (Blue, Evans)FDA Link
08/2010 - 07/2008
1Clindamycin (Cleocin)FDA LinkGeneric
03/2019
1CabergolineFDA LinkGeneric
02/2019
1Penicillin G (Benzylpenicillin)FDA LinkGeneric
05/2018
1Insulin (Novolin)FDA Link
01/2017
1BuffersIBA
08/2010
1Phosphates (Orthophosphate)IBA
08/2010
1Therapeutic UsesIBA
07/2008
1Meloxicam (Mobic)FDA LinkGeneric
03/2007
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2007
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2007
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2007
1Etodolac (Lodine)FDA LinkGeneric
03/2007
1Pharmaceutical PreparationsIBA
03/2007
1tiaramideIBA
03/2007
1Proteins (Proteins, Gene)FDA Link
12/2005
1Staphylococcal Protein A (Protein A)IBA
12/2005
1Growth Factor ReceptorsIBA
12/2005
1human ERBB2 proteinIBA
12/2005
1Trastuzumab (Herceptin)FDA Link
12/2005
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2005
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2005

Therapy/Procedure

2Therapeutics
01/2017 - 12/2005
2Sutures (Suture)
08/2010 - 07/2008
1Intravenous Injections
08/2010